TABLE 2.
Treatment group comparison of baseline and on-trial plasma isoflavone levels (nmol/l)
| Placebo N = 103 | ISP N = 121 | P-value* | |
|---|---|---|---|
| Daidzein (nmol/l) | |||
| Baseline | 11.9 (54.7) | 17.6 (52.0) | 0.59 |
| On-trial average | 41.5 (89.4) | 290.5 (330.0) | <.0001 |
| Genistein (nmol/l) | |||
| Baseline | 8.4 (35.6) | 14.9 (48.5) | 0.25 |
| On-trial average | 27.1 (87.8) | 354.0 (372.0) | <.0001 |
| Glycitein (nmol/l) | |||
| Baseline | 2.6 (6.9) | 2.0 (6.9) | 0.82 |
| On-trial average | 3.5 (7.6) | 10.4 (18.9) | <.0001 |
Values are Median (IQR), in nmol/l
*
Wilcoxon two-sample test